107 results on '"SERAFINI, MARTA"'
Search Results
2. Orthogonal IMiD-Degron Pairs Induce Selective Protein Degradation in Cells
3. Modeling skeletal dysplasia in Hurler syndrome using patient-derived bone marrow osteoprogenitor cells
4. Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency
5. Trial of a desktop virtual reality application as a method of exposure for test anxiety: a qualitative study
6. CARs are sharpening their weapons
7. Visualization of User’s Behavior in Indoor Virtual Environments Through Interactive Heatmaps
8. Click 1,2,3-triazoles in drug discovery and development: From the flask to the clinic?
9. AML alters bone marrow stromal cell osteogenic commitment via Notch signaling
10. Correction to “An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline”
11. Mutate and Conjugate: A Method to Enable Rapid In-Cell Target Validation
12. Desktop virtual reality as an exposure method for test anxiety: quantitative and qualitative feasibility study
13. Mutate and Conjugate: A Method to Enable Rapid In-Cell Target Validation
14. Drug Discovery for Soft Drugs on TRPV1 and TRPM8 Channels Using the Passerini Reaction
15. Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche
16. A Question of Frame: The Role of the Bone Marrow Stromal Niche in Myeloid Malignancies
17. An in vivo humanized model to study homing and sequestration of Plasmodium falciparum transmission stages in the bone marrow
18. Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden
19. P616: Cell-based noninvasive prenatal screening for a comprehensive fetal genome profiling for pathogenic submicroscopic CNVs in circulating trophoblasts from maternal blood
20. IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML
21. Isolation of single circulating trophoblasts from maternal circulation for noninvasive fetal copy number variant profiling
22. Overexpression of CXCR4 Enhances the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia
23. Tuned IL3-Zetakine Coupled to a CD33 Costimulatory Receptor As a Dual CAR for Safer and Selective Targeting of Acute Myeloid Leukemia
24. CAR.CD123-NK Cells Have an Equally Effective but Safer Off-Tumor/on-Target Profile As Compared to CARCD123-T Cells for the Treatment of Acute Myeloid Leukaemia
25. Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia
26. A Versatile and Sustainable Multicomponent Platform for the Synthesis of Protein Degraders: Proof-of-Concept Application to BRD4-Degrading PROTACs
27. MPSI Manifestations and Treatment Outcome: Skeletal Focus
28. CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy
29. GsαR201C and estrogen reveal different subsets of bone marrow adiponectin expressing osteogenic cells
30. An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline
31. STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca2+-entry modulators CIC-37 and CIC-39
32. Morphological and Immunophenotypical Changes of Human Bone Marrow Adipocytes in Marrow Metastasis and Myelofibrosis
33. CD14 positive cells accelerate hematopoietic stem cell engraftment
34. OP049: Automated isolation and genetic characterization of single circulating fetal trophoblasts in pregnant women
35. First-in-human phase I/II clinical trial of hematopoietic stem and progenitor cell gene therapy for Hurler syndrome: Favorable safety profile and extensive metabolic correction
36. Combining the Expression of CD33.CAR and CXCR4 to Increase CAR-CIK Cell Homing to Bone Marrow Niche and Leukemic Stem Cell Eradication in Acute Myeloid Leukemia
37. CD123 and CD33 Co-Targeting By Balanced Signaling on CAR-CIK Cells Reduces Potential Off-Target Toxicity While Preserving the Anti-Leukemic Activity of Acute Myeloid Leukemia
38. A Reliable and Sustainable Multicomponent Access to Protein Degraders
39. A Reliable and Sustainable Multicomponent Access to Protein Degraders
40. The [1,2,4]Triazolo[4,3‐a]pyridine as a New Player in the Field of IDO1 Catalytic Holo‐Inhibitors
41. Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia
42. A Reliable and Sustainable Multicomponent Access to Protein Degraders
43. A Reliable and Sustainable Multicomponent Access to Protein Degraders
44. Catch me if you can: how AML and its niche escape immunotherapy
45. Tritylamine as an Ammonia Surrogate in the Ugi Reaction Provides Access to Unprecedented 5-Sulfamido Oxazoles Using Burgess-type Reagents
46. From Stem Cells to Bone-Forming Cells
47. What’s in a Name? Drug Nomenclature and Medicinal Chemistry Trends using INN Publications
48. Harnessing Mesenchymal Stromal Cells for the Engineering of Human Hematopoietic Niches
49. 1,2,4-Oxadiazole-Bearing Pyrazoles as Metabolically Stable Modulators of Store-Operated Calcium Entry
50. The 115 Years Old Multicomponent Bargellini Reaction: Perspectives and New Applications
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.